Avoid common mistakes on your manuscript.
Correction to:
Wien Klin Wochenschr 2018
Unfortunately, the original version of this article contained two mistakes.
The text passage “It should be mentioned here that in the case of apixaban, dose adjustment is not based on GFR. A lower dosage of apixaban should be used if serum creatinine is ≥1.5 mg/dl (133 µmol/l) and either one of the following criteria is fulfilled: age ≥80 years or weight ≤60 kg.” is incorrect because GFR alone is a dose reduction criterion for apixaban in patients with NVAF if it falls below 30 ml/min.
In addition the sentence “There are specific recommendations for dose reduction of dabigatran and apixaban1 in patients ≥80 years, but not for rivaroxaban and edoxaban” is incorrect. The correct sentence should be “There are specific recommendations for dose reduction of dabigatran and—only in NVAF—apixaban in patients ≥80 years, but not for rivaroxaban and edoxaban.”
We apologize for the mistakes.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Gremmel, T., Niessner, A., Domanovits, H. et al. Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding. Wien Klin Wochenschr 131, 135 (2019). https://doi.org/10.1007/s00508-019-1467-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-019-1467-8